Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel proteasome inhibitor shows efficacy against human prostate carcinoma in vitro

Nov. 3, 2004

Novel quinoxaline topoisomerase I inhibitor

Nov. 3, 2004

New Chk1 kinase inhibitors under study at Abbott

Nov. 3, 2004

Novel Src kinase inhibitors covered by AstraZeneca patent

Nov. 3, 2004

Tumor responses in phase I study of Proxinium for head and neck cancer

Nov. 2, 2004

Orphan drug designation for BAY-43-9006 for renal cell carcinoma

Nov. 2, 2004

Novel hypoxia-targeting agents for tumor therapy

Nov. 2, 2004

Novel CDK2/CDK5 inhibitors claimed by IRM researchers

Nov. 2, 2004

Novel Chk1 inhibitors and their use covered by AstraZeneca patent

Nov. 2, 2004

New tubulin polymerization inhibitors prepared and tested at Aventis

Nov. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...